mid term +50,000%
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.